R.28 EPC Exceptions to patentability

(1)

Under Article 53(a), European patents shall not be granted in respect of biotechnological inventions which, in particular, concern the following:

(a)

processes for cloning human beings;

(b)

processes for modifying the germ line genetic identity of human beings;

uses of human embryos for industrial or commercial purposes;

(d)

processes for modifying the genetic identity of animals which are likely to cause them suffering without any substantial medical benefit to man or animal, and also animals resulting from such processes.

(2)

Under Article 53(b), European patents shall not be granted in respect of plants or animals exclusively obtained by means of an essentially biological process.

Amended by decision of the Administrative Council CA/D 6/17 of 29.06.2017 (OJ EPO 2017, A56), entered into force on 01.07.2017.

See decision of the Enlarged Board of Appeal G 2/06 (Annex I).

Source: http://www.epo.org/law-practice/legal-texts/html/epc/2016/e/r28.html

Date retrieved: 30 December 2018

37 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

X A.53 EPC Exceptions to patentability

EPC Implementing Rules

X Chapter V Biotechnological inventions

X R.27 EPC Patentable biotechnological inventions

EPO Guidelines - F The European Patent Application

X GL F IV 4.12 Product-by-process claim

EPO Guidelines - G Patentability

X GL G II 4.1 Matter contrary to " ordre public " or morality

X GL G II 5.2 Patentable biotechnological inventions

X GL G II 5.3 List of exceptions ( Rule 28 )

X GL G II 5.4 Plant and animal varieties, essentially biological processes for the production of plants or animals

X GL G II 5.4.1 Plant varieties

Offical Journal of the EPO

X OJ EPO 2017, A75 - Notice from the European Patent Office dated 4 August 2017 concerning the updating of the Guidelines for Examination in the European Patent Office

X OJ EPO 2017, A62 - Notice from the European Patent Office dated 3 July 2017 concerning the resumption of proceedings following the decision of the Administrative Council of 29 June 2017 to amend Rules 27 and 28 EPC in order to exclude from [..]

X OJ EPO 2017, A56 - Decision of the Administrative Council of 29 June 2017 amending Rules 27 and 28 of the Implementing Regulations to the European Patent Convention ( CA/D 6/17 )

X OJ EPO 2013, 42 - Decision of Technical Board of Appeal 3.3.04 dated 31 May 2012 T 1242/06 3.3.04

X OJ EPO 2012, 130 - Decision of the Enlarged Board of Appeal dated 9 December 2010 G 2/07

X OJ EPO 2011, 134 - Decision of the Enlarged Board of Appeal dated 15 February 2010 G 1/07

X OJ EPO 2010, 498 - Notice from the European Patent Office dated 7 July 2010 concerning inventions which involve the use of or concern biological material

X OJ EPO 2009, 306 - Decision of the Enlarged Board of Appeal dated 25 November 2008 G 2/06

Case Law Book: I Patentability

X CLR I B 2 of "ordre public" or morality

X CLR I B 2.1 28 EPC

X CLR I B 2.1.1 of exception under Rule 28(c) EPC

X CLR I B 2.1.2 of exception under Rule 28(d) EPC

X CLR I B 2.1.3 date

X CLR I B 2.2 53(a) EPC

X CLR I B 2.2.2.A Difference from test under Rule 28(d) EPC

Case Law Book: II Conditions to be met by an Application

X CLR II E 1.5.3.B Drafting of disclaimers - disclaimer shall not remove more than is necessary

X CLR II E 1.5.3.F Availiability of remaining subject matter at filing or priority date

Case Law Book: III Amendments

X CLR III H 1.1.3 of exclusions from patentability under the Vienna Convention

Case Law Book: VII Proceedings before the EPO

X CLR VII 1.3 a court or tribunal of an EU Member State

Case Law of the Enlarged Board

X G 0002/06 (Use of embryos/WARF) of 25.11.2008

X G 0002/12 () of 25.3.2015

X G 0002/13 () of 25.3.2015

General Case Law

X T 0522/04 (Stem cells/CALIFORNIA) of 28.5.2009

X T 1836/10 (Gewinnung von embryonalen Stammzellen/WÃRFEL) of 9.4.2013

X T 2221/10 (Culturing stem cells/TECHNION) of 4.2.2014

X T 2464/10 (Anticoagulant protein/IMPERIAL) of 25.5.2012

X T 1441/13 (Embryonic stem cells, disclaimer /ASTERIAS) of 9.9.2014

X T 1808/13 (Neurale VorlÃ¤uferzellen/BRÃSTLE) of 26.2.2015